DNA damage affects the tumour microenvironment via a range of molecular and cellular mechanisms; for example, it decreases genomic stability, activates immune pathways and upregulates programmed death‐ligand 1 (PD‐L1) expression, which increases the complexity of cancer treatment.42 This evidence concerns the gene CD274 and neoplasm.